EUVIMEDEUVIMED entdecken
Crossref

Protective effect of bromelain on some metabolic enzyme activities in tyloxapol‐induced hyperlipidemic rats

Ayşe Nurseli Sulumer, Esra Palabıyık, Bahri Avcı, Handan Uguz, Yeliz Demir iD, Muhammet Serhat Özaslan, Hakan Aşkın

Biotechnology and Applied Biochemistry · 2024

DOI: 10.1002/bab.2517 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biotechnology and Applied Biochemistry, 2024. Verfasst von Ayşe Nurseli Sulumer und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Biology and Genetics, Faculty of Science, Ataturk University, Erzurum, Turkey. Hauptthemen laut MEDLINE: Butyrylcholinesterase, Hyperlipidemias, Polyethylene Glycols. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 88 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Elevation of one or more plasma lipids, such as phospholipids, cholesterol esters, cholesterol, and triglycerides, is known as hyperlipidemia. In humans and experimental animals, bromelain, the primary active ingredient isolated from pineapple stems, has several positive effects, including anti‐tumor growth, anticoagulation, and anti‐inflammation. Hence, the purpose of this study was to determine the possible protective impact of bromelain on some metabolic enzymes (paraoxonase‐1, glutathione S ‐transferase, glutathione reductase, sorbitol dehydrogenase [SDH], aldose reductase [AR], butyrylcholinesterase [BChE], and acetylcholinesterase [AChE]), activity in the heart, kidney, and liver of rats with tyloxapol‐induced hyperlipidemia. Rats were divided into three groups: control group, HL‐control group (tyloxapol 400 mg/kg, i.p. administered group), and HL+bromelain (group receiving bromelain 250 mg/kg/o.d. prior to administration of tyloxapol 400 mg/kg, i.p.). BChE, SDH, and AR enzyme activities were significantly increased in all tissues in HL‐control compared to the control, whereas the activity of other studied enzymes was significantly decreased. Bromelain had a regulatory effect on all tissues and enzyme activities. In conclusion, these results prove that bromelain is a new mediator that decreases hyperlipidemia.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ButyrylcholinesteraseHyperlipidemiasPolyethylene GlycolsHumansRatsAnimalsAcetylcholinesteraseBromelains

Stichwörter der Autor:innen

bromelainenzyme activityhyperlipidemiatyloxapol

Substanzen

tyloxapolButyrylcholinesteraseAcetylcholinesteraseBromelainsPolyethylene Glycols

Autor:innen und Institutionen

  • Department of Molecular Biology and Genetics, Faculty of Science, Ataturk University, Erzurum, Turkey.
  • Department of Pharmacy Services, Nihat Delibalta Göle Vocational High School, Ardahan University, Ardahan, Turkey.

ORCID-Profile: Yeliz Demir

Zitieren

APA

Sulumer, A. N., Palabıyık, E., Avcı, B., Uguz, H., Demir, Y., Serhat Özaslan, M., & Aşkın, H. (2024). Protective effect of bromelain on some metabolic enzyme activities in tyloxapol‐induced hyperlipidemic rats. Biotechnology and Applied Biochemistry. https://doi.org/10.1002/bab.2517

Vancouver

Sulumer AN, Palabıyık E, Avcı B, Uguz H, Demir Y, Serhat Özaslan M, et al. Protective effect of bromelain on some metabolic enzyme activities in tyloxapol‐induced hyperlipidemic rats. Biotechnology and Applied Biochemistry. 2024. doi:10.1002/bab.2517

BibTeX
@article{Sulumer2024,
  author = {Sulumer, Ayşe Nurseli and Palabıyık, Esra and Avcı, Bahri and Uguz, Handan and Demir, Yeliz and Serhat Özaslan, Muhammet and Aşkın, Hakan},
  title = {Protective effect of bromelain on some metabolic enzyme activities in tyloxapol‐induced hyperlipidemic rats},
  journal = {Biotechnology and Applied Biochemistry},
  year = {2024},
  doi = {10.1002/bab.2517}
}
Kostenlos starten →